Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,461 public trials 1,143 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Active, Not Recruiting

Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer

NCT05498155

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Research Site Greeley, Colorado, United States
  • Research Site Loveland, Colorado, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Portland, Oregon, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

NCT06239467

Conditions
Advanced Cancer, Advanced Solid Tumors, Breast Cancer, +7 more
Locations
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • University of California San Diego UCSD La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag - Huntington Beach Newport Beach, California, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

NCT05870579

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • UCLA Jonsson Comp Cancer Center Los Angeles, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Novartis Investigative Site Shanghai, China
  • Novartis Investigative Site Saint-Cloud, Hauts De Seine, France
View all 13 locations
View Trial Details
Active, Not Recruiting

TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer

NCT06001762

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Eastern Maine Medical Center (Northern Light) Brewer, Maine, United States
  • New England Cancer Specialists Scarborough, Maine, United States
  • Boston Medical Center Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

NCT03488693

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Banner-University Medical Center Phoenix Phoenix, Arizona, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
View all 485 locations
View Trial Details
Active, Not Recruiting

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

NCT01937117

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details

Related conditions